181 related articles for article (PubMed ID: 9653167)
1. Poliovirus vaccine vectors elicit antigen-specific cytotoxic T cells and protect mice against lethal challenge with malignant melanoma cells expressing a model antigen.
Mandl S; Sigal LJ; Rock KL; Andino R
Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8216-21. PubMed ID: 9653167
[TBL] [Abstract][Full Text] [Related]
2. Preexisting immunity to poliovirus does not impair the efficacy of recombinant poliovirus vaccine vectors.
Mandl S; Hix L; Andino R
J Virol; 2001 Jan; 75(2):622-7. PubMed ID: 11134275
[TBL] [Abstract][Full Text] [Related]
3. Toward a poliovirus-based simian immunodeficiency virus vaccine: correlation between genetic stability and immunogenicity.
Tang S; van Rij R; Silvera D; Andino R
J Virol; 1997 Oct; 71(10):7841-50. PubMed ID: 9311872
[TBL] [Abstract][Full Text] [Related]
4. Recombinant polioviruses expressing hepatitis B virus-specific cytotoxic T-lymphocyte epitopes.
Cho SP; Lee B; Min MK
Vaccine; 2000 Jun; 18(25):2878-85. PubMed ID: 10812231
[TBL] [Abstract][Full Text] [Related]
5. Replication-Competent Foamy Virus Vaccine Vectors as Novel Epitope Scaffolds for Immunotherapy.
Lei J; Osen W; Gardyan A; Hotz-Wagenblatt A; Wei G; Gissmann L; Eichmüller S; Löchelt M
PLoS One; 2015; 10(9):e0138458. PubMed ID: 26397953
[TBL] [Abstract][Full Text] [Related]
6. Recombinant yellow fever viruses are effective therapeutic vaccines for treatment of murine experimental solid tumors and pulmonary metastases.
McAllister A; Arbetman AE; Mandl S; Peña-Rossi C; Andino R
J Virol; 2000 Oct; 74(19):9197-205. PubMed ID: 10982366
[TBL] [Abstract][Full Text] [Related]
7. Measles Vaccines Designed for Enhanced CD8
Busch E; Kubon KD; Mayer JKM; Pidelaserra-Martí G; Albert J; Hoyler B; Heidbuechel JPW; Stephenson KB; Lichty BD; Osen W; Eichmüller SB; Jäger D; Ungerechts G; Engeland CE
Viruses; 2020 Feb; 12(2):. PubMed ID: 32098134
[TBL] [Abstract][Full Text] [Related]
8. Poliovirus-specific major histocompatibility complex class I-restricted cytolytic T-cell epitopes in mice localize to neutralizing antigenic regions.
Kutubuddin M; Simons J; Chow M
J Virol; 1992 Oct; 66(10):5967-74. PubMed ID: 1382144
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC.
Maecker HT; Umetsu DT; DeKruyff RH; Levy S
J Immunol; 1998 Dec; 161(12):6532-6. PubMed ID: 9862678
[TBL] [Abstract][Full Text] [Related]
10. Heat shock fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class I presentation pathway.
Suzue K; Zhou X; Eisen HN; Young RA
Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13146-51. PubMed ID: 9371814
[TBL] [Abstract][Full Text] [Related]
11. Hierarchy among multiple H-2b-restricted cytotoxic T-lymphocyte epitopes within simian virus 40 T antigen.
Mylin LM; Bonneau RH; Lippolis JD; Tevethia SS
J Virol; 1995 Nov; 69(11):6665-77. PubMed ID: 7474076
[TBL] [Abstract][Full Text] [Related]
12. Therapy of murine tumors with recombinant Bordetella pertussis adenylate cyclase carrying a cytotoxic T cell epitope.
Fayolle C; Ladant D; Karimova G; Ullmann A; Leclerc C
J Immunol; 1999 Apr; 162(7):4157-62. PubMed ID: 10201941
[TBL] [Abstract][Full Text] [Related]
13. Induction of antigen-specific class I-restricted cytotoxic T cells by soluble proteins in vivo.
Raychaudhuri S; Tonks M; Carbone F; Ryskamp T; Morrow WJ; Hanna N
Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8308-12. PubMed ID: 1518862
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of nonreplicating recombinant vaccinia expressing HLA-A201 targeted or complete MART-1/Melan-A antigen.
Schütz A; Oertli D; Marti WR; Noppen C; Padovan E; Spagnoli GC; Heberer M; Zajac P
Cancer Gene Ther; 2001 Sep; 8(9):655-61. PubMed ID: 11593334
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity.
Shibagaki N; Udey MC
J Immunol; 2002 Mar; 168(5):2393-401. PubMed ID: 11859130
[TBL] [Abstract][Full Text] [Related]
16. Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL.
Brossart P; Goldrath AW; Butz EA; Martin S; Bevan MJ
J Immunol; 1997 Apr; 158(7):3270-6. PubMed ID: 9120283
[TBL] [Abstract][Full Text] [Related]
17. Mucosal immunization of cynomolgus macaques with two serotypes of live poliovirus vectors expressing simian immunodeficiency virus antigens: stimulation of humoral, mucosal, and cellular immunity.
Crotty S; Lohman BL; Lü FX; Tang S; Miller CJ; Andino R
J Virol; 1999 Nov; 73(11):9485-95. PubMed ID: 10516057
[TBL] [Abstract][Full Text] [Related]
18. Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity.
Blaney JE; Nobusawa E; Brehm MA; Bonneau RH; Mylin LM; Fu TM; Kawaoka Y; Tevethia SS
J Virol; 1998 Dec; 72(12):9567-74. PubMed ID: 9811690
[TBL] [Abstract][Full Text] [Related]
19. Induction and persistence of a cytotoxic T lymphocyte (CTL) response against a herpes simplex virus-specific CTL epitope expressed in a cellular protein.
Fu TM; Bonneau RH; Epler M; Tevethia MJ; Alam S; Verner K; Tevethia SS
Virology; 1996 Aug; 222(1):269-74. PubMed ID: 8806508
[TBL] [Abstract][Full Text] [Related]
20. Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor.
Mahon BP; Katrak K; Nomoto A; Macadam AJ; Minor PD; Mills KH
J Exp Med; 1995 Apr; 181(4):1285-92. PubMed ID: 7699320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
